Mathematical model of pulsed immunotherapy for superficial bladder cancer

被引:73
|
作者
Bunimovich-Mendrazitsky, Svetlana [1 ]
Byrne, Helen [2 ]
Stone, Lewi [1 ]
机构
[1] Tel Aviv Univ, Fac Life Sci, Dept Zool, Biomath Unit, IL-69978 Tel Aviv, Israel
[2] Ctr Math Med & Biol, Sch Math Sci, Nottingham NG7 2RD, England
关键词
transitional cell carcinoma (TCC); immune response; therapy schedule; impulsive differential equations;
D O I
10.1007/s11538-008-9344-z
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We present a theoretical study of superficial bladder cancer growth and its treatment via pulsed immunotherapy with Bacillus Calmette-Guerin (BCG), an attenuated strain of Mycobacterium bovis. BCG pulsed immunotherapy is a clinically established procedure for the treatment of superficial bladder cancer. In this paper, periodic BCG instillations are modeled using impulsive differential equations, which are studied using a combination of analytical and numerical techniques. In this way, we determine critical threshold values of the BCG instillation dose and rate of pulsing for successful treatment. We also identify treatment regimes in which tumor destruction occurs, but undesirable side effects are maintained at low levels by the immune system.
引用
收藏
页码:2055 / 2076
页数:22
相关论文
共 50 条
  • [31] EXPERIENCE WITH BACILLUS CALMETTE-GUERIN IN PATIENTS WITH SUPERFICIAL BLADDER-CARCINOMA - IMMUNOTHERAPY OF SUPERFICIAL BLADDER-CANCER
    CRISPEN, RG
    JOURNAL OF UROLOGY, 1984, 131 (03): : 558 - 558
  • [32] The impact of age on response of patients with superficial bladder cancer to intravesical immunotherapy
    Joudi, FN
    Smith, BJ
    O'Donnell, MA
    Konety, BR
    JOURNAL OF UROLOGY, 2006, 175 (04): : 272 - 272
  • [33] Treatment of superficial bladder cancer: A discussion on intravesical immunotherapy and intravesical chemotherapy
    Whelan, P
    EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (03) : 70 - 72
  • [34] Neutrophil granulocytes are essential during BCG immunotherapy of superficial bladder cancer
    Suttmann, H
    Riemensberger, J
    Böhle, A
    Goldmann, T
    Jocham, D
    Brandau, S
    JOURNAL OF UROLOGY, 2005, 173 (04): : 205 - 205
  • [35] Intravesical Immunotherapy of Superficial Bladder Cancer with Chitosan/Interleukin-12
    Zaharoff, David A.
    Hoffman, Benjamin S.
    Hooper, H. Brooks
    Benjamin, Compton J., Jr.
    Khurana, Kiranpreet K.
    Hance, Kenneth W.
    Rogers, Connie J.
    Pinto, Peter A.
    Schlom, Jeffrey
    Greiner, John W.
    CANCER RESEARCH, 2009, 69 (15) : 6192 - 6199
  • [36] The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy
    Joudi, FN
    Smith, BJ
    O'Donnell, MA
    Konety, BR
    JOURNAL OF UROLOGY, 2006, 175 (05): : 1634 - 1639
  • [37] BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY OF SUPERFICIAL BLADDER-CANCER
    LAMM, DL
    THOR, DE
    HARRIS, SC
    REYNA, JA
    STOGDILL, VD
    RADWIN, HM
    JOURNAL OF UROLOGY, 1980, 124 (01): : 38 - 42
  • [38] Additional Extension of the Mathematical Model for BCG Immunotherapy of Bladder Cancer and Its Validation by Auxiliary Tool
    Guzev, Ekaterina
    Halachmi, Sarel
    Bunimovich-Mendrazitsky, Svetlana
    INTERNATIONAL JOURNAL OF NONLINEAR SCIENCES AND NUMERICAL SIMULATION, 2019, 20 (06) : 675 - 689
  • [39] A MATHEMATICAL MODEL FOR THE IMMUNOTHERAPY OF ADVANCED PROSTATE CANCER
    Portz, Travis
    Kuang, Yang
    BIOMAT 2012: INTERNATIONAL SYMPOSIUM ON MATHEMATICAL AND COMPUTATIONAL BIOLOGY, 2013, : 70 - 85
  • [40] Adoptive immunotherapy for superficial bladder cancer with autologous macrophage activated killer cells
    Thiounn, N
    Pages, F
    Mejean, A
    Descotes, JL
    Fridman, WH
    Romet-Lemonne, JL
    JOURNAL OF UROLOGY, 2002, 168 (06): : 2373 - 2376